Robert A. Bradway

Chairman and Chief Executive Officer, Amgen

In 2006, Robert joined Amgen as Vice President of Operations Strategy. He was appointed to the Amgen Board of Directors in October 2011, and became Chairman in January 2013, and CEO in May 2012. Before Amgen, he was a managing director at Morgan Stanley in London. In 2017, Robert was elected PhRMA board chairman-elect.

Part of the Power List 2019

Breakthroughs at the bench, novel technologies and groundbreaking policies and regulation have helped the pharma industry grow from strength to strength. After months of collating reader nominations and judging overseen by a panel of industry experts, we proudly present The Medicine Maker 2019 Power List, featuring 100 of the industry’s pioneers across four categories: Industry Influencers, Business Captains, Masters of the Bench, and Champions of Change.

Go to The Power List 2019